This study may be the first randomized controlled diet intervention trial to examine the effect of carbohydrates by type and amount on symptomatic GERD.
Intrinsic Medicine has filed to raise investment via IPO. The firm is developing treatments for irritable bowel syndrome variants. Read more on INRX stock here.